Please try another search
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
Name | Age | Since | Title |
---|---|---|---|
Henry Chen | - | 2024 | Director |
Nan Zhang | - | 2024 | CEO & Director |
Pierson Yue Pan | - | 2024 | Director |
Haitao Zhao | - | 2024 | Director |
Viren Mehta | 74 | 2023 | Independent Director |
Ajit S. Shetty | 77 | 2023 | Independent Chairman |
Rui Yu | 49 | 2023 | Independent Director |
Jin Wang | - | 2024 | Independent Director |
Yuntao Cui | - | 2024 | Independent Director |
Hui Shao | 56 | 2023 | Co-Chief Executive Officer, President, Chief Business Officer & Executive Director |
Chunyuan Wu | 46 | 2024 | Chief Financial Officer & Director |
Chunyang Shao | - | 2024 | Director |
Adam Zhao | - | 2024 | Director |
Thomas Xue | - | 2024 | Director |
Zengjun Xu | - | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review